[go: up one dir, main page]

CN111303028B - A 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method - Google Patents

A 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method Download PDF

Info

Publication number
CN111303028B
CN111303028B CN202010187727.0A CN202010187727A CN111303028B CN 111303028 B CN111303028 B CN 111303028B CN 202010187727 A CN202010187727 A CN 202010187727A CN 111303028 B CN111303028 B CN 111303028B
Authority
CN
China
Prior art keywords
cyano
difluoromethyl
ortho
quinoline compound
alkenyl aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010187727.0A
Other languages
Chinese (zh)
Other versions
CN111303028A (en
Inventor
李蕾
王贺
周明东
毛书宽
刘璐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Shihua University
Original Assignee
Liaoning Shihua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Shihua University filed Critical Liaoning Shihua University
Priority to CN202010187727.0A priority Critical patent/CN111303028B/en
Publication of CN111303028A publication Critical patent/CN111303028A/en
Application granted granted Critical
Publication of CN111303028B publication Critical patent/CN111303028B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention provides a 4-cyano-2-difluoromethyl substituted quinoline compound and a synthesis method thereof. In the synthesis reaction, under the action of a photocatalyst, ortho-alkenyl aryl isonitrile is taken as a substrate and reacts with difluoromethyl triphenyl phosphonium bromide to synthesize the 4-cyano-2-difluoromethyl substituted quinoline compound. The synthesized 4-cyano-2-difluoromethyl substituted quinoline compound contains quinoline ring, difluoromethyl and cyano functional groups, and the quinoline ring, the difluoromethyl and the cyano functional groups have excellent activity in the aspect of biomedicine, thereby providing an effective thought for the design and synthesis of medicaments. The synthetic method provided by the invention is simple to operate, has good substrate universality and has step economy.

Description

一种4-氰基-2-二氟甲基取代的喹啉类化合物及合成方法A kind of 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthetic method

技术领域technical field

本发明涉及有机化学合成技术领域,尤其涉及一种4-氰基-2-二氟甲基取代的喹啉类化合物及合成方法。The invention relates to the technical field of organic chemical synthesis, in particular to a 4-cyano-2-difluoromethyl-substituted quinoline compound and a synthesis method.

背景技术Background technique

喹啉类化合物在医药、材料以及染料等方面有着广泛的应用。如2-氟烷基化喹诺林不仅可作为抗原生动物药物、抗结核药、PDE4抑制剂、心血管药、VR1受体拮抗剂和抗感染药等,还可作为金属催化反应的配体。另外,很多抗疟疾药、杀虫剂、消炎药、抗抑郁药中都含有喹啉骨架,且喹啉骨架也是一些生物碱全合成的重要中间体。因此,以简单底物出发合成喹啉化合物或直接对喹啉骨架修饰引入多种取代基吸引了化学工作者的浓厚的兴趣。Quinoline compounds are widely used in medicine, materials and dyes. For example, 2-fluoroalkylated quinolins can not only be used as anti-protozoal drugs, anti-tuberculosis drugs, PDE4 inhibitors, cardiovascular drugs, VR1 receptor antagonists and anti-infective drugs, but also as ligands for metal-catalyzed reactions . In addition, many antimalarial drugs, insecticides, anti-inflammatory drugs, and antidepressants contain quinoline skeletons, and quinoline skeletons are also important intermediates for the total synthesis of some alkaloids. Therefore, starting from simple substrates to synthesize quinoline compounds or directly modifying the quinoline skeleton to introduce various substituents has attracted strong interest of chemists.

通过对喹啉分子结构的逆合成分析得知,合成喹啉骨架的关键步骤在于吡啶环的构建。而碱催化的多米诺反应、过渡金属催化的环化反应或自由基环化反应均能够实现邻位烯基芳基异腈构建氮杂环化合物,因此,通过邻位烯基芳基异腈自由基反应能够合成喹啉类骨架。According to the retrosynthetic analysis of quinoline molecular structure, the key step in the synthesis of quinoline skeleton lies in the construction of pyridine ring. And the base-catalyzed domino reaction, transition metal-catalyzed cyclization reaction or free radical cyclization reaction can realize the construction of nitrogen heterocyclic compounds through the ortho alkenyl aryl isocyanide free radical The reaction enables the synthesis of quinoline-like backbones.

有机氟化合物因其独特的代谢稳定性、亲脂性和生物学特性而广泛应用于医学、农业以及生命和材料科学领域,因此,开发新的合成方法将氟或氟烷基团引入有机分子具有重要意义。在过去的几十年里,利用温和条件将二氟甲基引入有机分子中得到了广泛的研究。其中,二氟甲基自由基与不饱和烃的加成反应是引入二氟甲基常用的策略之一。可见光具有绿色、清洁、可持续等优点。最近,光氧化还原催化已成为自由基反应的一种强有力的策略。这一过程的关键特征是可见光能够通过光催化剂激发然后单电子转移来引发有机反应。因此,化学工作者们努力开发利用可见光氧化还原反应实现二氟甲基化的反应。氰基是一类具有较强吸电子性的取代基,其能够作为羰基的等排体,以改变一些小分子的物理性质,进而增强与靶向蛋白的相互作用,提高其药物活性。由此,综合考虑有机氟化合物代谢稳定性等的特性以及氰基提高药物活性的特性,如何以邻位烯基芳基异腈为底物合成含二氟甲基和氰基的喹啉类化学物成为人们亟待解决的问题。Organofluorine compounds are widely used in medicine, agriculture, and life and material sciences because of their unique metabolic stability, lipophilicity, and biological properties. Therefore, it is of great importance to develop new synthetic methods to introduce fluorine or haloalkyl groups into organic molecules. significance. The use of mild conditions to introduce difluoromethyl groups into organic molecules has been extensively studied in the past few decades. Among them, the addition reaction of difluoromethyl radicals with unsaturated hydrocarbons is one of the commonly used strategies for introducing difluoromethyl groups. Visible light has the advantages of being green, clean, and sustainable. Recently, photoredox catalysis has emerged as a powerful strategy for radical reactions. A key feature of this process is the ability of visible light to initiate organic reactions via photocatalyst excitation followed by single-electron transfer. Therefore, chemists have worked hard to develop difluoromethylation reactions using visible light redox reactions. The cyano group is a type of substituent with strong electron-withdrawing properties, which can act as an isostere of the carbonyl group to change the physical properties of some small molecules, thereby enhancing the interaction with the target protein and improving its drug activity. Therefore, considering the characteristics of the metabolic stability of organic fluorine compounds and the characteristics of the cyano group to enhance the drug activity, how to synthesize quinolines containing difluoromethyl and cyano groups using ortho-alkenyl aryl isocyanides as substrates. Things have become a problem that people urgently need to solve.

发明内容Contents of the invention

本发明提供一种4-氰基-2-二氟甲基取代的喹啉类化合物及合成方法,实现以邻位烯基芳基异腈为底物合成含二氟甲基和氰基的喹啉类化学物。The invention provides a 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method, which realizes the synthesis of quinolines containing difluoromethyl and cyano groups using ortho alkenyl aryl isocyanides as substrates. phyllochemicals.

本申请提供一种4-氰基-2-二氟甲基取代的喹啉类化合物,该化合物具有如Ⅰ所示的结构通式:The application provides a 4-cyano-2-difluoromethyl-substituted quinoline compound, which has a general structural formula as shown in I:

Figure BDA0002414782410000011
Figure BDA0002414782410000011

其中,R1选自环烷基、苯基、杂芳基或取代的苯基,杂芳基为吡啶基、噻吩基、呋喃基中的一种、两种或三种;苯基上的取代基为C1-C5烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种、两种或三种;Wherein, R is selected from cycloalkyl, phenyl, heteroaryl or substituted phenyl, and heteroaryl is one , two or three of pyridyl, thienyl, and furyl; The group is one, two or three of C1-C5 alkyl, alkoxy, trifluoromethyl, cyano, nitro, F, Cl, Br, I;

R2选自C1-C5氢、烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种、两种或三种。R 2 is selected from one, two or three of C1-C5 hydrogen, alkyl, alkoxy, trifluoromethyl, cyano, nitro, F, Cl, Br, I.

基于上述式Ⅰ的化合物,本申请还提供了一种4-氰基-2-二氟甲基取代的喹啉类化合物的合成方法,该方法包括:Based on the compound of the above-mentioned formula I, the application also provides a synthetic method of a 4-cyano-2-difluoromethyl-substituted quinoline compound, the method comprising:

S01:在反应器中依次加入邻位烯基芳基异腈、二氟甲基三苯基溴化磷、光催化剂和溶剂。S01: add ortho alkenyl aryl isonitrile, difluoromethyltriphenylphosphorus bromide, photocatalyst and solvent in sequence in the reactor.

按照预定比例分别量取邻位烯基芳基异腈、二氟甲基三苯基溴化磷、光催化剂和溶剂。在反应器中依次加入邻位烯基芳基异腈、二氟甲基三苯基溴化磷、光催化剂和溶剂。在本申请中,邻位烯基芳基异腈和二氟甲基三苯基溴化磷的摩尔比为1:1.1-2。光催化剂的用量为邻位烯基芳基异腈用量的2mol%。溶剂用量为每毫摩尔邻位烯基芳基异腈用溶剂0.5-10mL。较为优选地,邻位烯基芳基异腈和二氟甲基三苯基溴化磷的摩尔比为1:1.5。The o-alkenyl aryl isonitrile, difluoromethyltriphenylphosphorus bromide, photocatalyst and solvent are respectively measured according to a predetermined ratio. Add ortho alkenyl aryl isonitrile, difluoromethyltriphenylphosphorus bromide, photocatalyst and solvent in sequence in the reactor. In the present application, the molar ratio of ortho alkenyl aryl isonitrile to difluoromethyltriphenylphosphine bromide is 1:1.1-2. The amount of photocatalyst is 2 mol% of the amount of ortho alkenyl aryl isonitrile. The amount of solvent used is 0.5-10 mL of solvent per millimole of ortho alkenyl aryl isonitrile. More preferably, the molar ratio of ortho alkenyl aryl isonitrile to difluoromethyl triphenylphosphine bromide is 1:1.5.

在本申请中,邻位烯基芳基异腈的合成反应式为:In the present application, the synthetic reaction formula of ortho alkenyl aryl isocyanide is:

Figure BDA0002414782410000021
Figure BDA0002414782410000021

其中,R1选自环烷基、苯基、杂芳基或取代的苯基,所述杂芳基为吡啶基、噻吩基、或呋喃基一种、两种或三种;所述苯基上的取代基为C1-C5烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种、两种或三种;Wherein, R is selected from cycloalkyl, phenyl, heteroaryl or substituted phenyl, and said heteroaryl is one , two or three of pyridyl, thienyl, or furyl; said phenyl The substituents on are C1-C5 alkyl, alkoxy, trifluoromethyl, cyano, nitro, F, Cl, Br, I in one, two or three;

R2选自C1-C5氢、烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种、两种或三种。R 2 is selected from one, two or three of C1-C5 hydrogen, alkyl, alkoxy, trifluoromethyl, cyano, nitro, F, Cl, Br, I.

下面以(E)-2-(2-异氰基苯基)-3-苯基丙烯腈,即实施例1中的邻位烯基芳基异腈1a为例,根据上述合成反应式具体描述邻位烯基芳基异腈的合成过程。其余邻位烯基芳基异腈仅是与(E)-2-(2-异氰基苯基)-3-苯基丙烯腈1a的取代基不同,但合成步骤相同。Taking (E)-2-(2-isocyanophenyl)-3-phenylacrylonitrile, i.e. the ortho-alkenyl aryl isonitrile 1a in Example 1, as an example, it will be specifically described according to the above synthesis reaction formula Synthesis of ortho alkenyl aryl isocyanides. The remaining ortho-alkenyl aryl isonitriles are only different from (E)-2-(2-isocyanophenyl)-3-phenylacrylonitrile 1a in substituents, but the synthesis steps are the same.

S1:在含有邻硝基苯乙腈的甲醇溶液中,加入苯甲醛和哌啶。反应体系在70℃加热回流。反应4小时后冷却至室温,并收集黄色沉淀物。用甲醇重结晶沉淀物得到黄色固体产物(E)-2-(2-硝基苯基)-3-苯基丙烯腈,如式Ⅱ所示。S1: Add benzaldehyde and piperidine to a methanol solution containing o-nitrophenylacetonitrile. The reaction system was heated to reflux at 70°C. After 4 hours of reaction, it was cooled to room temperature, and a yellow precipitate was collected. The precipitate was recrystallized from methanol to obtain (E)-2-(2-nitrophenyl)-3-phenylacrylonitrile as a yellow solid product, as shown in Formula II.

S2:将(E)-2-(2-硝基苯基)-3-苯基丙烯腈、Sn粉末和乙醇混合后室温搅拌。在0℃下将HCl缓慢滴加到混合物中。滴加完成后在室温下再搅拌2小时。将混合物用饱和NaHCO3溶液淬灭并用CH2Cl2萃取。合并的有机层并用无水Na2SO4干燥,过滤,减压浓缩,残余物通过快速柱色谱纯化,使用己烷和乙酸乙酯作为洗脱剂,得到浅黄色固体(E)-2-(2-氨基苯基)-3-苯基丙烯腈,如式Ⅲ所示。S2: Mix (E)-2-(2-nitrophenyl)-3-phenylacrylonitrile, Sn powder and ethanol and stir at room temperature. HCl was slowly added dropwise to the mixture at 0 °C. After the dropwise addition was completed, it was stirred at room temperature for another 2 hours. The mixture was quenched with saturated NaHCO 3 solution and extracted with CH 2 Cl 2 . The combined organic layers were dried over anhydrous Na2SO4 , filtered, concentrated under reduced pressure, and the residue was purified by flash column chromatography using hexane and ethyl acetate as eluents to give (E)-2-( 2-aminophenyl)-3-phenylacrylonitrile, as shown in formula III.

S3:在装有滴液漏斗的干燥三颈瓶中,将(E)-2-(2-氨基苯基)-3-苯基丙烯腈和THF氮气条件下加入,并冷却至0℃。将乙酸酐与甲酸在55℃下反应2小时制得的甲酸乙酸酐转移至滴液漏斗中,在0℃下滴加至含有(E)-2-(2-氨基苯基)-3-苯基丙烯腈的溶液中。滴加完成后,将混合物升至室温并搅拌2小时。反应结束后将混合物用饱和NaHCO3溶液淬灭,并用CH2Cl2萃取三次。萃取液经Na2SO4干燥,减压浓缩得到浅白色固体(E)-N-(2-(1-氰基-2-苯基乙烯基)苯基)甲酰胺,如式1a所示。S3: In a dry three-necked flask equipped with a dropping funnel, add (E)-2-(2-aminophenyl)-3-phenylacrylonitrile and THF under nitrogen, and cool to 0°C. The formic acetic anhydride prepared by reacting acetic anhydride and formic acid at 55°C for 2 hours was transferred to the dropping funnel, and added dropwise to the solution containing (E)-2-(2-aminophenyl)-3-benzene at 0°C. in a solution of acrylonitrile. After the dropwise addition was complete, the mixture was warmed up to room temperature and stirred for 2 hours. After the reaction was complete, the mixture was quenched with saturated NaHCO 3 solution and extracted three times with CH 2 Cl 2 . The extract was dried over Na 2 SO 4 and concentrated under reduced pressure to obtain (E)-N-(2-(1-cyano-2-phenylethenyl)phenyl)formamide as a light white solid, as shown in formula 1a.

S4:在装有滴液漏斗的干燥三颈瓶中,于氮气氛围下加入THF、NEt3和(E)-N-(2-(1-氰基-2-苯基乙烯基)苯基)甲酰胺,并冷却至0℃。然后滴加POCl3,滴加完成后,将混合物在0℃搅拌2小时。反应结束后将混合物用饱和Na2CO3溶液淬灭并搅拌1小时。反应混合物用CH2Cl2萃取,合并的有机层并用无水Na2SO4干燥,过滤,减压浓缩,通过柱纯化该化合物得到(E)-2-(2-异氰基苯基)-3-苯基丙烯腈,如式Ⅴ所示。S4: In a dry three-necked flask equipped with a dropping funnel, add THF, NEt 3 and (E)-N-(2-(1-cyano-2-phenylethenyl)phenyl) under nitrogen atmosphere formamide and cooled to 0 °C. Then POCl3 was added dropwise, and after the dropwise addition was complete, the mixture was stirred at 0°C for 2 hours. After the reaction was completed, the mixture was quenched with saturated Na2CO3 solution and stirred for 1 hour. The reaction mixture was extracted with CH2Cl2 , the combined organic layers were dried over anhydrous Na2SO4 , filtered, concentrated under reduced pressure, and the compound was purified by column to give (E)-2-(2-isocyanophenyl)- 3-phenylacrylonitrile, as shown in formula V.

Figure BDA0002414782410000031
Figure BDA0002414782410000031

对制备得到的(E)-2-(2-异氰基苯基)-3-苯基丙烯腈1a进行NMR(NuclearMagnetic Resonance Spectroscopy,核磁共振谱),得到附图2所示的H谱图、附图3所示的C谱图、以及如下数据:NMR (NuclearMagnetic Resonance Spectroscopy, nuclear magnetic resonance spectrum) is carried out to the prepared (E)-2-(2-isocyanophenyl)-3-phenylacrylonitrile 1a, obtain the H spectrogram shown in accompanying drawing 2, The C spectrogram shown in accompanying drawing 3, and following data:

1HNMR(400MHz,CDCl3)δ7.93-7.91(m,2H),7.58-7.56(m,1H),7.52-7.42(m,7H); 1 HNMR (400MHz, CDCl 3 ) δ7.93-7.91 (m, 2H), 7.58-7.56 (m, 1H), 7.52-7.42 (m, 7H);

13C NMR(100MHz,CDCl3)δ169.8,149.0,132.9,132.2,131.5,130.0,129.9,129.5,129.1,128.4,124.5,117.1,106.6; 13 C NMR (100MHz, CDCl 3 ) δ169.8, 149.0, 132.9, 132.2, 131.5, 130.0, 129.9, 129.5, 129.1, 128.4, 124.5, 117.1, 106.6;

HRMS(ESI):calcd for C16H10N2([M+H]+)231.0917,found.231.0921.HRMS(ESI):calcd for C 16 H 10 N 2 ([M+H] + )231.0917,found.231.0921.

在本申请中,光催化剂选自曙红Y、曙红B、玫瑰红、4CzIPN(中文名称:2,4,5,6-四(9-咔唑基)-间苯二腈),fac-Ir(ppy)3(中文名称:面式-三(2-苯基吡啶)合铱配合物)中的一种或多种。溶剂选自N,N-二甲基甲酰胺(英文名称:N,N-Dimethylformamide;英文简称:DMF)、N,N-二甲基乙酰胺(英文名称:N,N-Dimethylacetamide;英文简称:DMAc)、二甲基亚砜(英文名称:Dimethyl sulfoxide;英文简称:DMSO)、二氯甲烷、乙腈、1,4-二氧六环(英文名称:1,4-dioxane)、1,2-二氯乙烷(英文名称:1,2-Dichloroethane;英文简称:DCE)、四氢呋喃(英文名称:Tetrahydrofuran;英文简称:THF)、乙醇、甲醇中的一种或两种。In this application, the photocatalyst is selected from eosin Y, eosin B, rose bengal, 4CzIPN (Chinese name: 2,4,5,6-tetra(9-carbazolyl)-isophthalonitrile), fac- One or more of Ir(ppy) 3 (Chinese name: face-tri(2-phenylpyridine) iridium complex). The solvent is selected from N,N-dimethylformamide (English name: N,N-Dimethylformamide; English abbreviation: DMF), N,N-dimethylacetamide (English name: N,N-Dimethylacetamide; English abbreviation: DMAc), dimethyl sulfoxide (English name: Dimethyl sulfoxide; English abbreviation: DMSO), dichloromethane, acetonitrile, 1,4-dioxane (English name: 1,4-dioxane), 1,2- One or both of dichloroethane (English name: 1,2-Dichloroethane; English abbreviation: DCE), tetrahydrofuran (English name: Tetrahydrofuran; English abbreviation: THF), ethanol, and methanol.

S02:在可见光照射、氮气氛围条件下,常温搅拌反应,得到产物。S02: Under the conditions of visible light irradiation and nitrogen atmosphere, stir and react at room temperature to obtain the product.

在可见光照射、氮气氛围条件下,常温下搅拌反应,得到产物。其中,产物的生成反应式为:Under the conditions of visible light irradiation and nitrogen atmosphere, the reaction was stirred at room temperature to obtain the product. Wherein, the generation reaction formula of product is:

Figure BDA0002414782410000032
Figure BDA0002414782410000032

上述反应式中,标号1即为邻位烯基芳基异腈,标号2为二氟甲基三苯基溴化磷,标号3即为具有结构式Ⅰ的4-氰基-2-二氟甲基取代的喹啉类化合物。在本申请中,可见光可以选用功率为10W的LED灯,搅拌时间为12h。In the above reaction formula, the label 1 is the ortho-alkenyl aryl isocyanide, the label 2 is difluoromethyltriphenylphosphonium bromide, and the label 3 is the 4-cyano-2-difluoromethane with structural formula I Substituted quinoline compounds. In this application, the visible light can be an LED lamp with a power of 10W, and the stirring time is 12h.

S03:采用旋转蒸发仪抽掉所述产物中的溶剂,得到粗产物。S03: Use a rotary evaporator to remove the solvent in the product to obtain a crude product.

S04:所述粗产物经柱层析,得到4-氰基-2-二氟甲基取代的喹啉类化合物。S04: The crude product was subjected to column chromatography to obtain 4-cyano-2-difluoromethyl-substituted quinolines.

将粗产物通过层析柱进行柱层析,得到4-氰基-2-二氟甲基取代的喹啉类化合物。其中,柱层析的洗脱剂为石油醚和乙酸乙酯的混合溶剂。The crude product was subjected to column chromatography to obtain 4-cyano-2-difluoromethyl-substituted quinolines. Wherein, the eluent of the column chromatography is a mixed solvent of petroleum ether and ethyl acetate.

在本申请中,为分析光催化剂和溶剂对合成4-氰基-2-二氟甲基取代的喹啉类化合物的影响,本申请还以一种4-氰基-2-二氟甲基取代的喹啉类化合物为例进行条件优化和筛选,具体数据如表1所示。其中,此次条件优化和筛选所用的4-氰基-2-二氟甲基取代的喹啉类化合物的结构式及合成反应式分别如下:In the present application, in order to analyze the influence of photocatalyst and solvent on the quinoline compound substituted by synthetic 4-cyano-2-difluoromethyl, the application also uses a kind of 4-cyano-2-difluoromethyl The substituted quinoline compound was taken as an example for condition optimization and screening, and the specific data are shown in Table 1. Among them, the structural formula and synthetic reaction formula of the 4-cyano-2-difluoromethyl-substituted quinoline compound used in the condition optimization and screening are as follows:

结构式:

Figure BDA0002414782410000041
Structural formula:
Figure BDA0002414782410000041

合成反应式:

Figure BDA0002414782410000042
Synthesis reaction formula:
Figure BDA0002414782410000042

合成反应的条件为:氮气条件、0.2mmol邻位烯基芳基异腈1a、0.3mmol二氟甲基三苯基溴化磷、光催化剂、1mL溶剂、10W蓝光LEDs照射反应12h。表2中特别标注的合成条件不同于该合成反应的条件,即c)8W蓝光LEDs;d)无光照;e)空气中。The conditions of the synthesis reaction are: nitrogen condition, 0.2mmol o-alkenyl aryl isonitrile 1a, 0.3mmol difluoromethyltriphenylphosphorus bromide, photocatalyst, 1mL solvent, 10W blue LEDs irradiation reaction for 12h. The synthesis conditions specially marked in Table 2 are different from the conditions of the synthesis reaction, namely c) 8W blue LEDs; d) no light; e) in air.

表1:以实施例1为基础的对比例的相关数据Table 1: The relevant data of the comparative example based on embodiment 1

Figure BDA0002414782410000043
Figure BDA0002414782410000043

由表1可知,序号为4的实验中,当光催化剂为2mol%的fac-Ir(ppy)3、溶剂为DMAc、10W蓝光LEDs照射时,合成的4-氰基-2-二氟甲基取代的喹啉类化合物具有较高的收率,即70%。It can be seen from Table 1 that in the experiment numbered 4, when the photocatalyst was 2mol% fac-Ir(ppy) 3 , the solvent was DMAc, and 10W blue LEDs were irradiated, the synthesized 4-cyano-2-difluoromethyl The substituted quinolines had a higher yield, ie 70%.

本发明的实施例提供的技术方案可以包括以下有益效果:The technical solutions provided by the embodiments of the present invention may include the following beneficial effects:

本发明提供的4-氰基-2-二氟甲基取代的喹啉类化合物及合成方法中,在光催化剂的作用下,以邻位烯基芳基异腈为底物,与二氟甲基三苯基溴化磷反应,合成4-氰基-2-二氟甲基取代的喹啉类化合物。合成的4-氰基-2-二氟甲基取代的喹啉类化合物中含有喹啉环、二氟甲基及氰基官能团,且喹啉环、二氟甲基及氰基官能团在生物医药方面有着优越的活性,为药物的设计与合成提供了有效的思路。本发明提供的合成方法操作简单、底物普适性好,具有步骤经济性。In the 4-cyano-2-difluoromethyl-substituted quinoline compound and the synthesis method provided by the invention, under the action of photocatalyst, the ortho-alkenyl aryl isocyanide is used as a substrate, and difluoroform The 4-cyano-2-difluoromethyl substituted quinolines were synthesized by the reaction of triphenylphosphonium bromide. The synthesized 4-cyano-2-difluoromethyl substituted quinoline compounds contain quinoline ring, difluoromethyl and cyano functional groups, and the quinoline ring, difluoromethyl and cyano functional groups are widely used in biomedicine It has superior activity and provides an effective idea for the design and synthesis of drugs. The synthesis method provided by the invention has simple operation, good substrate universality and step economy.

应当理解的是,以上的一般描述和后文的细节描述仅是示例性和解释性的,并不能限制本发明。It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention.

附图说明Description of drawings

为了更清楚地说明本申请的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,显而易见地,对于本领域普通技术人员而言,在不付出创造性劳动性的前提下,还可以根据这些附图获得其他的附图。In order to illustrate the technical solution of the present application more clearly, the accompanying drawings used in the embodiments will be briefly introduced below. Obviously, for those of ordinary skill in the art, on the premise of not paying creative labor, Additional drawings can also be derived from these drawings.

图1为本发明实施例提供的4-氰基-2-二氟甲基取代的喹啉类化合物的合成方法的流程示意图;Figure 1 is a schematic flow diagram of the synthesis method of 4-cyano-2-difluoromethyl-substituted quinoline compounds provided by the examples of the present invention;

图2为本发明实施例提供的(E)-2-(2-异氰基苯基)-3-苯基丙烯腈1a的H谱图;Fig. 2 is the H spectrogram of (E)-2-(2-isocyanophenyl)-3-phenylacrylonitrile 1a provided by the embodiment of the present invention;

图3为本发明实施例提供的(E)-2-(2-异氰基苯基)-3-苯基丙烯腈1a的C谱图;Fig. 3 is the C spectrogram of (E)-2-(2-isocyanophenyl)-3-phenylacrylonitrile 1a provided by the embodiment of the present invention;

图4为本发明实施例提供的实施例1中4-氰基-2-二氟甲基取代的喹啉类化合物3a的H谱图;Fig. 4 is the H spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3a in Example 1 provided by the examples of the present invention;

图5为本发明实施例提供的实施例1中4-氰基-2-二氟甲基取代的喹啉类化合物3a的C谱图;Figure 5 is the C spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3a in Example 1 provided by the Examples of the present invention;

图6为本发明实施例提供的实施例1中4-氰基-2-二氟甲基取代的喹啉类化合物3a的F谱图;Figure 6 is the F spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3a in Example 1 provided by the examples of the present invention;

图7为本发明实施例提供的实施例2中4-氰基-2-二氟甲基取代的喹啉类化合物3b的H谱图;Figure 7 is the H spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3b in Example 2 provided by the examples of the present invention;

图8为本发明实施例提供的实施例2中4-氰基-2-二氟甲基取代的喹啉类化合物3b的C谱图;Figure 8 is the C spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3b in Example 2 provided by the examples of the present invention;

图9为本发明实施例提供的实施例2中4-氰基-2-二氟甲基取代的喹啉类化合物3b的F谱图;Figure 9 is the F spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3b in Example 2 provided by the examples of the present invention;

图10为本发明实施例提供的实施例3中4-氰基-2-二氟甲基取代的喹啉类化合物3c的H谱图;Figure 10 is the H spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3c in Example 3 provided by the examples of the present invention;

图11为本发明实施例提供的实施例3中4-氰基-2-二氟甲基取代的喹啉类化合物3c的C谱图;Figure 11 is the C spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3c in Example 3 provided by the examples of the present invention;

图12为本发明实施例提供的实施例3中4-氰基-2-二氟甲基取代的喹啉类化合物3c的F谱图;Figure 12 is the F spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3c in Example 3 provided in the examples of the present invention;

图13为本发明实施例提供的实施例4中4-氰基-2-二氟甲基取代的喹啉类化合物3d的H谱图;Figure 13 is the H spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3d in Example 4 provided by the Examples of the present invention;

图14为本发明实施例提供的实施例4中4-氰基-2-二氟甲基取代的喹啉类化合物3d的C谱图;Figure 14 is the C spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3d in Example 4 provided by the Examples of the present invention;

图15为本发明实施例提供的实施例4中4-氰基-2-二氟甲基取代的喹啉类化合物3d的F谱图;Figure 15 is the F spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3d in Example 4 provided by the Examples of the present invention;

图16为本发明实施例提供的实施例5中4-氰基-2-二氟甲基取代的喹啉类化合物3e的H谱图;Figure 16 is the H spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3e in Example 5 provided by the Examples of the present invention;

图17为本发明实施例提供的实施例5中4-氰基-2-二氟甲基取代的喹啉类化合物3e的C谱图;Figure 17 is the C spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3e in Example 5 provided by the Examples of the present invention;

图18为本发明实施例提供的实施例5中4-氰基-2-二氟甲基取代的喹啉类化合物3e的F谱图。Figure 18 is the F spectrum of the 4-cyano-2-difluoromethyl-substituted quinoline compound 3e in Example 5 provided by the Examples of the present invention.

具体实施方式Detailed ways

下面以具体的实施方案对本发明进行进一步的说明。本申请中光催化剂和溶剂的可选项较多,形成的实施例较多,为便于描述本发明内容以及减少篇幅,下述实施例中仅以发明内容中确定的最优条件:光催化剂fac-Ir(ppy)3、溶剂DMAc、10W蓝光LEDs照射为例进行说明,但这并不限制本发明的保护范围。The present invention will be further described below with specific embodiments. In this application, there are many options for photocatalysts and solvents, and there are many embodiments. For the convenience of describing the content of the present invention and reducing the space, only the optimal conditions determined in the content of the invention are used in the following examples: photocatalyst fac- Ir(ppy) 3 , solvent DMAc, and 10W blue LEDs irradiation are taken as examples for illustration, but this does not limit the protection scope of the present invention.

请参考附图1,附图1示出了本申请实施例提供的4-氰基-2-二氟甲基取代的喹啉类化合物的合成方法的流程示意图。下述具体实施例的描述均以附图1为基础。Please refer to the accompanying drawing 1, which shows a schematic flow diagram of the synthesis method of the 4-cyano-2-difluoromethyl-substituted quinoline compounds provided in the examples of the present application. The description of the following specific embodiments is based on the accompanying drawing 1 .

实施例1Example 1

本发明实施例提供一种4-氰基-2-二氟甲基取代的喹啉类化合物3a,该4-氰基-2-二氟甲基取代的喹啉类化合物3a具有如下结构式:The embodiment of the present invention provides a 4-cyano-2-difluoromethyl-substituted quinoline compound 3a, the 4-cyano-2-difluoromethyl-substituted quinoline compound 3a has the following structural formula:

Figure BDA0002414782410000061
Figure BDA0002414782410000061

本发明实施例还提供了4-氰基-2-二氟甲基取代的喹啉类化合物3a的合成方法,该方法具体包括:The embodiment of the present invention also provides a synthesis method of 4-cyano-2-difluoromethyl-substituted quinoline compound 3a, which specifically includes:

S101:在反应器中依次加入0.2mmol(46.1mg)邻位烯基芳基异腈1a、0.3mmol(117.8mg)二氟甲基三苯基溴化磷2、2mol%(2.6mg)fac-Ir(ppy)3、1mL N,N-二甲基甲酰胺(DMAc);S101: Add 0.2mmol (46.1mg) ortho alkenyl aryl isonitrile 1a, 0.3mmol (117.8mg) difluoromethyltriphenylphosphonium bromide 2, 2mol% (2.6mg) fac- Ir(ppy) 3 , 1 mL N,N-dimethylformamide (DMAc);

S102:在功率为10W的蓝光LED照射、氮气氛围条件下,常温搅拌12h,得到产物;其中,该产物的生成反应式为:S102: Under the conditions of blue light LED irradiation with a power of 10W and a nitrogen atmosphere, stir at room temperature for 12 hours to obtain the product; wherein, the formation reaction formula of the product is:

Figure BDA0002414782410000062
Figure BDA0002414782410000062

S103:反应结束后,采用旋转蒸发仪抽掉产物中的溶剂,得到粗产物;S103: After the reaction is finished, use a rotary evaporator to remove the solvent in the product to obtain a crude product;

S104:以石油醚和乙酸乙酯的混合溶剂为洗脱剂,粗产物通过柱层析,得到39.2mg4-氰基-2-二氟甲基取代的喹啉类化合物3a,分离收率为70%。S104: Using a mixed solvent of petroleum ether and ethyl acetate as the eluent, the crude product was subjected to column chromatography to obtain 39.2 mg of 4-cyano-2-difluoromethyl-substituted quinoline compound 3a, with an isolated yield of 70 %.

对制备得到的4-氰基-2-二氟甲基取代的喹啉类化合物3a进行NMR(NuclearMagnetic Resonance Spectroscopy,核磁共振谱),得到附图4所示的H谱图、附图5所示的C谱图、附图6所示的F谱图以及如下数据:NMR (NuclearMagnetic Resonance Spectroscopy, nuclear magnetic resonance spectrum) is carried out to the quinoline compound 3a that the substituted 4-cyano-2-difluoromethyl that prepares obtains, obtain the H spectrogram shown in accompanying drawing 4, shown in accompanying drawing 5 The C spectrogram, the F spectrogram shown in accompanying drawing 6 and following data:

1H NMR(400MHz,CDCl3)δ8.35(d,J=8.4Hz,1H),8.29(dd,J=0.8,8.4Hz,1H),7.97-7.93(m,1H),7.90-7.86(m,1H),7.59-7.57(m,3H),7.49-7.46(m,2H),6.69(t,J=54.0Hz,1H); 1 H NMR (400MHz, CDC l3 ) δ8.35 (d, J = 8.4Hz, 1H), 8.29 (dd, J = 0.8, 8.4Hz, 1H), 7.97-7.93 (m, 1H), 7.90-7.86 ( m,1H),7.59-7.57(m,3H),7.49-7.46(m,2H),6.69(t,J=54.0Hz,1H);

13C NMR(100MHz,CDCl3)δ149.9(t,J=23.1Hz),146.3,137.7,132.9,131.7,131.0,130.8,129.8,129.7,128.8,126.4,125.2,120.7,114.3,112.6(t,J=241.3Hz); 13 C NMR (100MHz, CDC l3 ) δ149.9(t, J=23.1Hz), 146.3, 137.7, 132.9, 131.7, 131.0, 130.8, 129.8, 129.7, 128.8, 126.4, 125.2, 120.7, 114.3, 112.6(t ,J=241.3Hz);

19F NMR(377MHz,CDCl3)δ-112.6(s,2F); 19 F NMR (377MHz, CDC 13 ) δ-112.6 (s, 2F);

HRMS(ESI):calcd for C17H10F2N2([M+H]+)281.0885,found.281.089。HRMS (ESI): calcd for C 17 H 10 F 2 N 2 ([M + H] + ) 281.0885, found. 281.089.

实施例2Example 2

本发明实施例提供一种4-氰基-2-二氟甲基取代的喹啉类化合物3b,该4-氰基-2-二氟甲基取代的喹啉类化合物3b具有如下结构式:The embodiment of the present invention provides a 4-cyano-2-difluoromethyl-substituted quinoline compound 3b, the 4-cyano-2-difluoromethyl-substituted quinoline compound 3b has the following structural formula:

Figure BDA0002414782410000071
Figure BDA0002414782410000071

本发明实施例还提供了4-氰基-2-二氟甲基取代的喹啉类化合物3b的合成方法,该方法具体包括:The embodiment of the present invention also provides a synthesis method of 4-cyano-2-difluoromethyl-substituted quinoline compound 3b, which specifically includes:

S201:在反应器中依次加入0.2mmol(31.2mg)邻位烯基芳基异腈1b、0.3mmol(117.8mg)二氟甲基三苯基溴化磷2、2mol%(2.6mg)fac-Ir(ppy)3、1mL N,N-二甲基甲酰胺(DMAc);S201: Add 0.2mmol (31.2mg) ortho alkenyl aryl isonitrile 1b, 0.3mmol (117.8mg) difluoromethyltriphenylphosphine bromide 2, 2mol% (2.6mg) fac- Ir(ppy) 3 , 1 mL N,N-dimethylformamide (DMAc);

S202:在功率为10W的蓝光LED照射、氮气氛围条件下,常温搅拌12h,得到产物;其中,该产物的生成反应式为:S202: Under the condition of 10W blue LED irradiation and nitrogen atmosphere, stir at room temperature for 12 hours to obtain the product; wherein, the formation reaction formula of the product is:

Figure BDA0002414782410000072
Figure BDA0002414782410000072

S203:反应结束后,采用旋转蒸发仪抽掉产物中的溶剂,得到粗产物;S203: After the reaction is completed, use a rotary evaporator to remove the solvent in the product to obtain a crude product;

S204:以石油醚和乙酸乙酯的混合溶剂为洗脱剂,粗产物通过柱层析,得到39.2mg4-氰基-2-二氟甲基取代的喹啉类化合物3b,分离收率为53%。S204: Using a mixed solvent of petroleum ether and ethyl acetate as the eluent, the crude product was subjected to column chromatography to obtain 39.2 mg of 4-cyano-2-difluoromethyl-substituted quinoline compound 3b, with an isolated yield of 53 %.

对制备得到的4-氰基-2-二氟甲基取代的喹啉类化合物3b进行NMR(NuclearMagnetic Resonance Spectroscopy,核磁共振谱),得到附图7所示的H谱图、附图8所示的C谱图、附图9所示的F谱图以及如下数据:NMR (NuclearMagnetic Resonance Spectroscopy, nuclear magnetic resonance spectrum) is carried out to the quinoline compound 3b that the substituted 4-cyano-2-difluoromethyl that prepares obtains, obtain the H spectrogram shown in accompanying drawing 7, shown in accompanying drawing 8 The C spectrogram, the F spectrogram shown in accompanying drawing 9 and the following data:

1H NMR(400MHz,CDCl3)δ8.35(d,J=8.4Hz,1H),8.28(dd,J=0.8,8.4Hz,1H),7.97-7.92(m,1H),7.89-7.85(m,1H),7.48-7.44(m,1H),7.39-7.37(m,1H),7.27-7.25(m,2H),6.68(t,J=54.0Hz,1H),2.47(s,3H); 1 H NMR (400MHz, CDCl 3 ) δ8.35 (d, J = 8.4Hz, 1H), 8.28 (dd, J = 0.8, 8.4Hz, 1H), 7.97-7.92 (m, 1H), 7.89-7.85 ( m,1H),7.48-7.44(m,1H),7.39-7.37(m,1H),7.27-7.25(m,2H),6.68(t,J=54.0Hz,1H),2.47(s,3H) ;

13C NMR(100MHz,CDCl3)δ149.9(t,J=23.0Hz),146.3,138.7,137.8,132.8,131.7,131.0,130.8,130.6,130.2,128.7,126.8,126.4,125.2,120.5,114.4,112.2(t,J=241.0Hz),21.5; 13 C NMR (100MHz, CDCl 3 ) δ149.9 (t, J=23.0Hz), 146.3, 138.7, 137.8, 132.8, 131.7, 131.0, 130.8, 130.6, 130.2, 128.7, 126.8, 126.4, 125.2, 120.5, 114.4 ,112.2(t,J=241.0Hz),21.5;

19F NMR(377MHz,CDCl3)δ-113.0(s,2F); 19 F NMR (377MHz, CDCl 3 ) δ-113.0 (s, 2F);

HRMS(ESI):calcd for C18H12F2N2([M+H]+)295.1041,found.295.1044。HRMS (ESI): calcd for C 18 H 12 F 2 N 2 ([M+H] + ) 295.1041, found. 295.1044.

实施例3Example 3

本发明实施例提供一种4-氰基-2-二氟甲基取代的喹啉类化合物3c,该4-氰基-2-二氟甲基取代的喹啉类化合物3c具有如下结构式:The embodiment of the present invention provides a 4-cyano-2-difluoromethyl-substituted quinoline compound 3c, the 4-cyano-2-difluoromethyl-substituted quinoline compound 3c has the following structural formula:

Figure BDA0002414782410000073
Figure BDA0002414782410000073

本发明实施例还提供了4-氰基-2-二氟甲基取代的喹啉类化合物3c的合成方法,该方法具体包括:The embodiment of the present invention also provides a synthesis method of 4-cyano-2-difluoromethyl-substituted quinoline compound 3c, which specifically includes:

S301:在反应器中依次加入0.2mmol(47.2mg)邻位烯基芳基异腈1c、0.3mmol(117.8mg)二氟甲基三苯基溴化磷2、2mol%(2.6mg)fac-Ir(ppy)3、1mL N,N-二甲基甲酰胺(DMAc);S301: Add 0.2mmol (47.2mg) ortho alkenyl aryl isonitrile 1c, 0.3mmol (117.8mg) difluoromethyltriphenylphosphonium bromide 2, 2mol% (2.6mg) fac- Ir(ppy) 3 , 1 mL N,N-dimethylformamide (DMAc);

S302:在功率为10W的蓝光LED照射、氮气氛围条件下,常温搅拌12h,得到产物;其中,该产物的生成反应式为:S302: Under the conditions of blue light LED irradiation with a power of 10W and a nitrogen atmosphere, stir at room temperature for 12 hours to obtain the product; wherein, the formation reaction formula of the product is:

Figure BDA0002414782410000081
Figure BDA0002414782410000081

S303:反应结束后,采用旋转蒸发仪抽掉产物中的溶剂,得到粗产物;S303: After the reaction is completed, use a rotary evaporator to remove the solvent in the product to obtain a crude product;

S304:以石油醚和乙酸乙酯的混合溶剂为洗脱剂,粗产物通过柱层析,得到13.2mg4-氰基-2-二氟甲基取代的喹啉类化合物3c,分离收率为23%。S304: Using a mixed solvent of petroleum ether and ethyl acetate as the eluent, the crude product was subjected to column chromatography to obtain 13.2 mg of 4-cyano-2-difluoromethyl-substituted quinoline compound 3c with an isolated yield of 23 %.

对制备得到的4-氰基-2-二氟甲基取代的喹啉类化合物3c进行NMR(NuclearMagnetic Resonance Spectroscopy,核磁共振谱),得到附图10所示的H谱图、附图11所示的C谱图、附图12所示的F谱图以及如下数据:NMR (NuclearMagnetic Resonance Spectroscopy, nuclear magnetic resonance spectrum) is carried out to the quinoline compound 3c that the substituted 4-cyano-2-difluoromethyl that prepares obtains, obtain the H spectrogram shown in accompanying drawing 10, shown in accompanying drawing 11 The C spectrogram, the F spectrogram shown in accompanying drawing 12 and following data:

1H NMR(400MHz,CDCl3)δ8.35(d,J=8.4Hz,1H),8.28(dd,J=0.8,8.0Hz,1H),7.99-7.95(m,1H),7.91-7.87(m,1H),7.66(dd,J=1.2,5.2Hz,1H),7.35-7.33(m,1H),7.27-7.25(m,1H),6.79(t,J=54.0Hz,1H); 1 H NMR (400MHz, CDCl 3 ) δ8.35 (d, J = 8.4Hz, 1H), 8.28 (dd, J = 0.8, 8.0Hz, 1H), 7.99-7.95 (m, 1H), 7.91-7.87 ( m,1H),7.66(dd,J=1.2,5.2Hz,1H),7.35-7.33(m,1H),7.27-7.25(m,1H),6.79(t,J=54.0Hz,1H);

13C NMR(100MHz,CDCl3)δ150.3(t,J=22.8Hz),146.5,132.2,131.8,131.2,131.1,130.8,130.6,129.3,127.8,126.4,125.3,122.1,114.1,112.2(t,J=241.5Hz); 13 C NMR (100MHz, CDCl 3 ) δ150.3(t, J=22.8Hz), 146.5, 132.2, 131.8, 131.2, 131.1, 130.8, 130.6, 129.3, 127.8, 126.4, 125.3, 122.1, 114.1, 112.2(t ,J=241.5Hz);

19F NMR(377MHz,CDCl3)δ-113.1(s,2F); 19 F NMR (377MHz, CDCl 3 ) δ-113.1 (s, 2F);

HRMS(ESI):calcd for C15H8F2N2S([M+H]+)287.0449,found.287.0453。HRMS (ESI): calcd for C 15 H 8 F 2 N 2 S ([M+H] + ) 287.0449, found. 287.0453.

实施例4Example 4

本发明实施例提供一种4-氰基-2-二氟甲基取代的喹啉类化合物3d,该4-氰基-2-二氟甲基取代的喹啉类化合物3d具有如下结构式:The embodiment of the present invention provides a 4-cyano-2-difluoromethyl-substituted quinoline compound 3d, the 4-cyano-2-difluoromethyl-substituted quinoline compound 3d has the following structural formula:

Figure BDA0002414782410000082
Figure BDA0002414782410000082

本发明实施例还提供了4-氰基-2-二氟甲基取代的喹啉类化合物3d的合成方法,该方法具体包括:The embodiment of the present invention also provides a synthesis method of 4-cyano-2-difluoromethyl-substituted quinoline compound 3d, which specifically includes:

S401:在反应器中依次加入0.2mmol(47.2mg)邻位烯基芳基异腈1d、0.3mmol(117.8mg)二氟甲基三苯基溴化磷2、2mol%(2.6mg)fac-Ir(ppy)3、1mL N,N-二甲基甲酰胺(DMAc);S401: Add 0.2mmol (47.2mg) o-alkenyl aryl isonitrile 1d, 0.3mmol (117.8mg) difluoromethyltriphenylphosphine bromide 2, 2mol% (2.6mg) fac- Ir(ppy) 3 , 1 mL N,N-dimethylformamide (DMAc);

S402:在功率为10W的蓝光LED照射、氮气氛围条件下,常温搅拌12h,得到产物;其中,该产物的生成反应式为:S402: Under the conditions of blue light LED irradiation with a power of 10W and a nitrogen atmosphere, stir at room temperature for 12 hours to obtain the product; wherein, the formation reaction formula of the product is:

Figure BDA0002414782410000091
Figure BDA0002414782410000091

S403:反应结束后,采用旋转蒸发仪抽掉产物中的溶剂,得到粗产物;S403: After the reaction is completed, use a rotary evaporator to remove the solvent in the product to obtain a crude product;

S404:以石油醚和乙酸乙酯的混合溶剂为洗脱剂,粗产物通过柱层析,得到22.5mg4-氰基-2-二氟甲基取代的喹啉类化合物3d,分离收率为39%。S404: Using a mixed solvent of petroleum ether and ethyl acetate as the eluent, the crude product was subjected to column chromatography to obtain 22.5 mg of 4-cyano-2-difluoromethyl-substituted quinoline compound 3d with an isolated yield of 39 %.

对制备得到的4-氰基-2-二氟甲基取代的喹啉类化合物3d进行NMR(NuclearMagnetic Resonance Spectroscopy,核磁共振谱),得到附图13所示的H谱图、附图14所示的C谱图、附图15所示的F谱图以及如下数据:NMR (NuclearMagnetic Resonance Spectroscopy, nuclear magnetic resonance spectrum) is carried out to the quinoline compound 3d that the substituted 4-cyano-2-difluoromethyl that prepares obtains, obtain the H spectrogram shown in accompanying drawing 13, shown in accompanying drawing 14 The C spectrogram, the F spectrogram shown in accompanying drawing 15 and the following data:

1H NMR(400MHz,CDCl3)δ8.29-8.26(m,1H),8.18-8.16(m,1H),7.86-7.82(m,2H),6.91(t,J=54.4Hz,1H),3.55-3.47(m,1H),2.38-2.32(m,2H),1.99-1.93(m,2H),1.91-1.85(m,2H),1.84-1.81(m,1H),1.55-1.44(m,3H); 1 H NMR (400MHz, CDCl 3 ) δ8.29-8.26 (m, 1H), 8.18-8.16 (m, 1H), 7.86-7.82 (m, 2H), 6.91 (t, J = 54.4Hz, 1H), 3.55-3.47(m,1H),2.38-2.32(m,2H),1.99-1.93(m,2H),1.91-1.85(m,2H),1.84-1.81(m,1H),1.55-1.44(m ,3H);

13C NMR(100MHz,CDCl3)δ150.8(t,J=25.4Hz),144.5(t,J=1.8Hz),143.3,130.8,130.5,130.3,127.6,124.6,118.4,117.9(t,J=238.4Hz),115.6,38.7,30.8,26.9,25.4; 13 C NMR (100MHz, CDCl 3 ) δ150.8(t, J=25.4Hz), 144.5(t, J=1.8Hz), 143.3, 130.8, 130.5, 130.3, 127.6, 124.6, 118.4, 117.9(t, J =238.4Hz), 115.6, 38.7, 30.8, 26.9, 25.4;

19F NMR(377MHz,CDCl3)δ-110.5(s,2F); 19 F NMR (377MHz, CDCl 3 ) δ-110.5 (s, 2F);

HRMS(ESI):calcd for C17H16F2N2([M+H]+)287.1354,found.287.1359。HRMS (ESI): calcd for C 17 H 16 F 2 N 2 ([M+H] + ) 287.1354, found. 287.1359.

实施例5Example 5

本发明实施例提供一种4-氰基-2-二氟甲基取代的喹啉类化合物3e,该4-氰基-2-二氟甲基取代的喹啉类化合物3e具有如下结构式:The embodiment of the present invention provides a 4-cyano-2-difluoromethyl-substituted quinoline compound 3e, the 4-cyano-2-difluoromethyl-substituted quinoline compound 3e has the following structural formula:

Figure BDA0002414782410000092
Figure BDA0002414782410000092

本发明实施例还提供了4-氰基-2-二氟甲基取代的喹啉类化合物3e的合成方法,该方法具体包括:The embodiment of the present invention also provides a synthesis method of 4-cyano-2-difluoromethyl-substituted quinoline compound 3e, which specifically includes:

S501:在反应器中依次加入0.2mmol(49.6mg)邻位烯基芳基异腈1e、0.3mmol(117.8mg)二氟甲基三苯基溴化磷2、2mol%(2.6mg)fac-Ir(ppy)3、1mL N,N-二甲基甲酰胺(DMAc);S501: Add 0.2mmol (49.6mg) ortho alkenyl aryl isonitrile 1e, 0.3mmol (117.8mg) difluoromethyl triphenylphosphine bromide 2, 2mol% (2.6mg) fac- Ir(ppy) 3 , 1 mL N,N-dimethylformamide (DMAc);

S502:在功率为10W的蓝光LED照射、氮气氛围条件下,常温搅拌12h,得到产物;其中,该产物的生成反应式为:S502: Under the condition of blue light LED irradiation with a power of 10W and a nitrogen atmosphere, stir at room temperature for 12 hours to obtain the product; wherein, the formation reaction formula of the product is:

Figure BDA0002414782410000093
Figure BDA0002414782410000093

S503:反应结束后,采用旋转蒸发仪抽掉产物中的溶剂,得到粗产物;S503: After the reaction is completed, use a rotary evaporator to remove the solvent in the product to obtain a crude product;

S504:以石油醚和乙酸乙酯的混合溶剂为洗脱剂,粗产物通过柱层析,得到25.1mg4-氰基-2-二氟甲基取代的喹啉类化合物3e,分离收率为42%。S504: Using a mixed solvent of petroleum ether and ethyl acetate as the eluent, the crude product was subjected to column chromatography to obtain 25.1 mg of 4-cyano-2-difluoromethyl-substituted quinoline compound 3e, with an isolated yield of 42 %.

对制备得到的4-氰基-2-二氟甲基取代的喹啉类化合物3e进行NMR(NuclearMagnetic Resonance Spectroscopy,核磁共振谱),得到附图16所示的H谱图、附图17所示的C谱图、附图18所示的F谱图以及如下数据:NMR (NuclearMagnetic Resonance Spectroscopy, nuclear magnetic resonance spectrum) is carried out to the quinoline compound 3e that the substituted 4-cyano-2-difluoromethyl that prepares obtains, obtain the H spectrogram shown in accompanying drawing 16, shown in accompanying drawing 17 The C spectrogram, the F spectrogram shown in accompanying drawing 18 and the following data:

1H NMR(400MHz,CDCl3)δ8.31(dd,J=5.6,9.2Hz,1H),7.98(dd,J=2.8,9.2Hz,1H),7.70-7.65(m,1H),7.59-7.57(m,3H),7.47-7.45(m,2H),6.67(t,J=54.0Hz,1H); 1 H NMR (400MHz, CDCl 3 ) δ8.31(dd, J=5.6, 9.2Hz, 1H), 7.98(dd, J=2.8, 9.2Hz, 1H), 7.70-7.65(m, 1H), 7.59- 7.57(m,3H),7.47-7.45(m,2H),6.67(t,J=54.0Hz,1H);

13C NMR(100MHz,CDCl3)δ164.1(d,J=254.0Hz),151.1(t,J=23.3Hz),147.4(d,J=13.0Hz),137.0,132.6,130.0,129.7,128.9,127.6(d,J=9.8Hz),123.5,121.7(d,J=25.8Hz),120.7(d,J=1.4Hz),114.6(d,J=20.9Hz),114.1,112.4(t,J=241.6Hz); 13 C NMR (100MHz, CDCl 3 ) δ164.1(d, J=254.0Hz), 151.1(t, J=23.3Hz), 147.4(d, J=13.0Hz), 137.0, 132.6, 130.0, 129.7, 128.9 ,127.6(d,J=9.8Hz),123.5,121.7(d,J=25.8Hz),120.7(d,J=1.4Hz),114.6(d,J=20.9Hz),114.1,112.4(t,J = 241.6Hz);

19F NMR(377MHz,CDCl3)δ-104.7(s,1F),-112.9(s,2F); 19 F NMR (377MHz, CDCl 3 ) δ-104.7(s, 1F), -112.9(s, 2F);

HRMS(ESI):calcd for C17H9F3N2([M+H]+)299.0791,found.299.0794。HRMS (ESI): calcd for C 17 H 9 F 3 N 2 ([M+H] + ) 299.0791, found. 299.0794.

本领域技术人员在考虑说明书及实践这里发明的公开后,将容易想到本发明的其它实施方案。本申请旨在涵盖本发明的任何变型、用途或者适应性变化,这些变型、用途或者适应性变化遵循本发明的一般性原理并包括本发明未公开的本技术领域中的公知常识或惯用技术手段。说明书和实施例仅被视为示例性的,本发明的真正范围和精神由下面的权利要求指出。Other embodiments of the invention will be readily apparent to those skilled in the art from consideration of the specification and practice of the invention disclosure herein. This application is intended to cover any modification, use or adaptation of the present invention, these modifications, uses or adaptations follow the general principles of the present invention and include common knowledge or conventional technical means in the technical field not disclosed in the present invention . The specification and examples are to be considered exemplary only, with a true scope and spirit of the invention being indicated by the following claims.

应当理解的是,诸如“第一”和“第二”等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。本发明并不局限于上面已经描述并在附图中示出的精确结构,并且可以在不脱离其范围进行各种修改和改变。本发明的范围仅由所附的权利要求来限制。It should be understood that relational terms such as "first" and "second", etc., are only used to distinguish one entity or operation from another and do not necessarily require or imply a relationship between these entities or operations. There is no such actual relationship or order between them. The present invention is not limited to the precise constructions which have been described above and shown in the drawings, and various modifications and changes may be made without departing from the scope thereof. The scope of the invention is limited only by the appended claims.

Claims (7)

1.一种4-氰基-2-二氟甲基取代的喹啉类化合物的合成方法,其特征在于,所述方法包括:1. a kind of synthetic method of the quinoline compound that 4-cyano group-2-difluoromethyl replaces, it is characterized in that, described method comprises: 在反应器中依次加入邻位烯基芳基异腈、二氟甲基三苯基溴化磷、光催化剂和溶剂;其中,所述邻位烯基芳基异腈的结构式为
Figure FDA0003951906200000011
R1选自环烷基、苯基、杂芳基或取代的苯基,所述杂芳基为吡啶基、噻吩基、呋喃基中的一种;所述苯基上的取代基为C1-C5烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种、两种或三种;R2选自氢、C1-C5烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种;所述二氟甲基三苯基溴化磷的结构式为
Figure FDA0003951906200000012
所述光催化剂选自fac-Ir(ppy)3;所述溶剂选自N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲基亚砜、乙腈中的一种或两种;
In the reactor, add ortho alkenyl aryl isocyanide, difluoromethyltriphenylphosphorus bromide, photocatalyst and solvent successively; Wherein, the structural formula of the ortho alkenyl aryl isocyanide is
Figure FDA0003951906200000011
R 1 is selected from cycloalkyl, phenyl, heteroaryl or substituted phenyl, and the heteroaryl is one of pyridyl, thienyl, and furyl; the substituent on the phenyl is C1- One, two or three of C5 alkyl, alkoxy, trifluoromethyl, cyano, nitro, F, Cl, Br, I; R2 is selected from hydrogen , C1-C5 alkyl, alkane One of oxygen, trifluoromethyl, cyano, nitro, F, Cl, Br, I; the structural formula of the difluoromethyl triphenylphosphonium bromide is
Figure FDA0003951906200000012
The photocatalyst is selected from fac-Ir(ppy) 3 ; the solvent is selected from one of N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, and acetonitrile or both;
在可见光照射、氮气氛围条件下,常温搅拌反应,得到产物;Under the conditions of visible light irradiation and nitrogen atmosphere, the reaction was stirred at room temperature to obtain the product; 采用旋转蒸发仪抽掉所述产物中的溶剂,得到粗产物;A rotary evaporator was used to remove the solvent in the product to obtain a crude product; 所述粗产物经柱层析,得到4-氰基-2-二氟甲基取代的喹啉类化合物。The crude product was subjected to column chromatography to obtain 4-cyano-2-difluoromethyl-substituted quinolines.
2.根据权利要求1所述的合成方法,其特征在于,所述产物的生成反应式为:2. synthetic method according to claim 1, is characterized in that, the generating reaction formula of described product is:
Figure FDA0003951906200000013
Figure FDA0003951906200000013
3.根据权利要求1所述的合成方法,其特征在于,所述邻位烯基芳基异腈和所述二氟甲基三苯基溴化磷的摩尔比为1:1.1-2。3. synthetic method according to claim 1, is characterized in that, the mol ratio of described ortho alkenyl aryl isocyanide and described difluoromethyltriphenylphosphorus bromide is 1:1.1-2. 4.根据权利要求1所述的合成方法,其特征在于,所述光催化剂的用量为所述邻位烯基芳基异腈用量的2mol%。4. The synthesis method according to claim 1, characterized in that, the amount of the photocatalyst is 2mol% of the amount of the ortho alkenyl aryl isonitrile. 5.根据权利要求1所述的合成方法,其特征在于,所述溶剂用量为每毫摩尔邻位烯基芳基异腈用溶剂0.5-10mL。5. The synthetic method according to claim 1, characterized in that, the amount of solvent used is 0.5-10 mL of solvent per millimole of ortho alkenyl aryl isonitrile. 6.根据权利要求1所述的合成方法,其特征在于,所述邻位烯基芳基异腈的合成反应式为:6. synthetic method according to claim 1, is characterized in that, the synthetic reaction formula of described ortho alkenyl aryl isocyanide is:
Figure FDA0003951906200000021
Figure FDA0003951906200000021
其中,R1选自环烷基、苯基、杂芳基或取代的苯基,所述杂芳基为吡啶基、噻吩基、或呋喃基一种;所述苯基上的取代基为C1-C5烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种、两种或三种;Wherein, R is selected from cycloalkyl, phenyl, heteroaryl or substituted phenyl, and the heteroaryl is a kind of pyridyl, thienyl, or furyl; the substituent on the phenyl is C1 -One, two or three of C5 alkyl, alkoxy, trifluoromethyl, cyano, nitro, F, Cl, Br, I; R2选自氢、C1-C5烷基、烷氧基、三氟甲基、氰基、硝基、F、Cl、Br、I中的一种。R 2 is selected from one of hydrogen, C1-C5 alkyl, alkoxy, trifluoromethyl, cyano, nitro, F, Cl, Br, I.
7.根据权利要求1所述的合成方法,其特征在于,所述柱层析的洗脱剂为石油醚和乙酸乙酯的混合溶剂。7. synthetic method according to claim 1, is characterized in that, the eluent of described column chromatography is the mixed solvent of sherwood oil and ethyl acetate.
CN202010187727.0A 2020-03-17 2020-03-17 A 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method Active CN111303028B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010187727.0A CN111303028B (en) 2020-03-17 2020-03-17 A 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010187727.0A CN111303028B (en) 2020-03-17 2020-03-17 A 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method

Publications (2)

Publication Number Publication Date
CN111303028A CN111303028A (en) 2020-06-19
CN111303028B true CN111303028B (en) 2023-01-24

Family

ID=71149685

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010187727.0A Active CN111303028B (en) 2020-03-17 2020-03-17 A 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method

Country Status (1)

Country Link
CN (1) CN111303028B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113264882A (en) * 2021-04-14 2021-08-17 四川轻化工大学 Preparation method of 1-difluoromethyl phenyl ketone isoquinoline
CN113773250B (en) * 2021-10-08 2023-07-25 湖北工业大学 5-cyano-8-amido quinoline compound and preparation method thereof
CN114014805B (en) * 2021-12-16 2023-08-11 南宁师范大学 Preparation method of trifluoromethylated 2,4-quinolinedione compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105017259A (en) * 2015-06-08 2015-11-04 浙江大学 Trifluoromethyl containing quinazoline derivative and preparation method and application thereof
CN106632087A (en) * 2016-12-30 2017-05-10 江西师范大学 The preparation method of 4-aryl-2-(2-(sulfur trifluoromethyl) aryl) quinazoline

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105017259A (en) * 2015-06-08 2015-11-04 浙江大学 Trifluoromethyl containing quinazoline derivative and preparation method and application thereof
CN106632087A (en) * 2016-12-30 2017-05-10 江西师范大学 The preparation method of 4-aryl-2-(2-(sulfur trifluoromethyl) aryl) quinazoline
CN109053599A (en) * 2016-12-30 2018-12-21 江西师范大学 4-aryl-2- (2- (sulfur trifluoromethyl) aryl) quinazoline compound

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Regioselective Cyanation of Six-Membered N-Heteroaromatic Compounds Under Metal-, Activator-, Base- and Solvent-Free Conditions;Bikash Kumar Sarmah 等;《Adv. Synth. Catal.》;20191113;第361卷;第5616-5625页 *
Trifluoromethylation/Difluoromethylation-Initiated Radical Cyclization …… Quinolines;Shukuan Mao 等;《Adv. Synth. Catal.》;20200403;第361卷;2274-2279 *

Also Published As

Publication number Publication date
CN111303028A (en) 2020-06-19

Similar Documents

Publication Publication Date Title
Zhang et al. Metal-Free Direct C–H Cyanoalkylation of Quinoxalin-2 (1 H)-Ones by Organic Photoredox Catalysis
CN111303028B (en) A 4-cyano-2-difluoromethyl-substituted quinoline compound and its synthesis method
Liu et al. Cu (II)-catalyzed C–H amidation/cyclization of azomethine imines with dioxazolones via acyl nitrenes: A direct access to diverse 1, 2, 4-triazole derivatives
Zhou et al. Visible-Light-Induced Multicomponent Cascade Cycloaddition of N-Propargyl Aromatic Amines, Cyclobutanone Oxime Esters, and K2S2O5: Access to Cyanoalkylsulfonylated Quinolines
Shen et al. Rh (III)-catalyzed simultaneous [3+ 3]/[5+ 1] annulation of 1-arylpyrazolidinones with gem-difluorocyclopropenes leading to fluorinated pyridopyrimidinone derivatives
CN103113308B (en) Method for preparing dihydropyrimidinone derivative
CN112645958A (en) Chiral spiro pyrazolone compound and preparation method thereof
Zeng et al. A metal-free approach for brønsted acid promoted C–H alkylation of heteroarenes with alkyl peroxides
Mao et al. Construction of CF3-Functionalized Fully Substituted Benzonitriles through Rauhut–Currier Reaction Initiated [3+ 3] Benzannulation
Gao et al. Palladium-Catalyzed Tandem Cyclization of Functional Diarylalkynes and Isocyanides for the Assembly of Isochromeno [4, 3-c] quinolines
CN111393437B (en) Trisubstituted indolizine compound and its preparation method
CN114349703A (en) A kind of trifluoromethyl-4-cyanopyrazole compound, its preparation method and application
CN110343087B (en) Synthesis and preparation method of isoindolinone derivatives
CN108440526B (en) A kind of chiral barbiturate spirotetrahydroquinoline compound and preparation method thereof
CN107602452A (en) A kind of synthetic method of 3 acyl pyridine class compound
CN116253697B (en) Method for synthesizing quinone benzothiazole compound by taking dichloro naphthoquinone and methylamine compound as raw materials
CN111303029B (en) 4-cyano-2-trifluoromethyl substituted quinoline compound and synthetic method thereof
CN101798282A (en) Multi-substituted fluorine-containing pyridine
CN107445914B (en) A kind of 2,2,5-trisubstituted 1,3,4 oxadiazole derivative and its synthesis method
CN112125843B (en) A kind of preparation method of 3-hydroxymethyl-4-phenyl-3,4-dihydroquinolinone compound
CN117105845A (en) An electrophilic trifluoromethylselenide reagent and its preparation method and application
CN110483344B (en) A kind of cycloalkyl-containing β-hydroxy sulfone compound and its synthesis method
CN107382782A (en) A kind of synthetic method of polyaryl substituted naphthol derivative
CN109608455B (en) Synthesis method of indazolo [2,3-a ] quinoline and derivatives thereof
CN114773294A (en) Preparation method of ebselen compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant